Mahmoud Aryan

Mahmoud Aryan

Auto-generated profile, based on publicly available information

Mahmoud Aryan

Department of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2020 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
PDF file
NMNabeel Moon
Nabeel Moon
MAMahmoud Aryan
Mahmoud Aryan
DWDonevan Westerveld
Donevan Westerveld
SNSunina Nathoo
Sunina Nathoo
SGSarah Glover
Sarah Glover
AKAmir Y Kamel
Amir Y Kamel

19 January 2023 in Hepatology
Verified
Journal Article
Closed access
CHChristine C. Hsu
Christine C. Hsu
JDJennifer L. Dodge
Jennifer L. Dodge
EWEthan Weinberg
Ethan Weinberg
GIGene Im
Gene Im
JKJimin Ko
Jimin Ko
BLBrian P. Lee
Brian P. Lee
Background: Early liver transplantation for alcohol-associated hepatitis is controversial in part because patients may recover, and obviate the need for liver transplantation. Methods: In this retrospective study among 5 ACCELERATE-AH sites, we randomly sampled patients evaluated and then declined for liver transplantation for alcohol-associated hepatitis. All had Model of End-Stage Liver Disease (MELD) >20 and <6 months of abstinence. Recompensation was defined as MELD <15 without variceal bleeding, ascites, or overt HE requiring treatment. Multilevel mixed effects linear regression was used to calculate probabilities of recompensation; multivariable Cox regression was used for mortality analyses. Results: Among 145 patients [61% men; median abstinence time and MELD-Na was 33 days (interquartile range: 13–70) and 31 (interquartile range: 26–36), respectively], 56% were declined for psychosocial reasons. Probability of 30-day, 90-day, 6-month, and 1-year survival were 76% (95% CI, 68%–82%), 59% (95% CI, 50%–66%), 49% (95% CI, 40%–57%), and 46% (95% CI, 37%–55%), respectively. Probability of 1-year recompensation was low at 10.0% (95% CI, 4.5%–15.4%). Among patients declined because of clinical improvement, 1-year probability of recompensation was 28.0% (95% CI, 5.7%–50.3%). Among survivors, median MELD-Na at 30 days, 90 days, and 1-year were 29 (interquartile range: 22–38), 19 (interquartile range : 14–29), and 11 (interquartile range : 7–17). Increased MELD-Na (adjusted HR: 1.13, p<0.001) and age (adjusted HR: 1.03, p<0.001) were associated with early (≤90 d) death, and only history of failed alcohol rehabilitation (adjusted HR: 1.76, p=0.02) was associated with late death. Conclusions: Liver recompensation is infrequent among severe alcohol-associated hepatitis patients declined for liver transplantation. Higher MELD-Na and age were associated with short-term mortality, whereas only history of failed alcohol rehabilitation was associated with long-term mortality. The distinction between survival and liver recompensation merits further attention.

1 January 2024 in Clinical Liver Disease
Verified
Journal Article
Closed access
MAMahmoud Aryan
Mahmoud Aryan
TJThomas Michael Ruli Jr
Thomas Michael Ruli Jr
MSMohamed Shoreibah
Mohamed Shoreibah

19 November 2021 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
EAEllery Altshuler
Ellery Altshuler
JKJesse Kirkpatrick
Jesse Kirkpatrick
MAMahmoud Aryan
Mahmoud Aryan
FMFrank Miralles
Frank Miralles
Alpha-gal syndrome (AGS) is a hypersensitivity reaction to mammalian meat that develops after tick bite exposure. AGS was first described in 2009 and testing for the allergy has become available in the last decade. We report the case of a 56-year-old farmer with a history of frequent lone star tick bites who presented with a 7-year history of diffuse urticaria occurring hours after eating red meat. AGS is likely underdiagnosed because of the unusual presentation of the allergy, historic lack of available testing, and deficiency of physician knowledge about the condition. Recognition of AGS is important both to help alleviate symptom burden and to avoid iatrogenesis. Patients with AGS should not receive products containing mammalian products, such as cat-gut suture, porcine-derived heart valves, and bovine-derived vaccines. Patients with AGS may present in a variety of clinical environments and physicians of all kinds should be able to recognise the symptoms.

1 January 2022 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
MAMahmoud Aryan
Mahmoud Aryan
RJRavi Jariwala
Ravi Jariwala
BABasem Alkurdi
Basem Alkurdi
SPShajan Peter
Shajan Peter
MSMohamed Shoreibah
Mohamed Shoreibah

25 May 2022 in Journal of Clinical and Translational Research
Verified
Journal Article
Open access
MAMahmoud Aryan
Mahmoud Aryan
RJRavi Jariwala
Ravi Jariwala
BABasem Alkurdi
Basem Alkurdi
SPShajan Peter
Shajan Peter
MSMohamed Shoreibah
Mohamed Shoreibah
Background: Gastric antral vascular ectasia (GAVE) is characterized by angiodysplastic lesions and is a rare form of gastrointestinal bleeding. Given the multiple patterns, GAVE can be misclassified Aim: We analyzed the misclassification of GAVE amongst patients undergoing esophagogastroduodenoscopy (EGD) Methods: We performed a retrospective review of 941 EGDs between 2017-2019. Inclusion criteria included findings of GAVE on EGD ± biopsy. Correct classification was based on visual EGD findings. Outcome variables included misclassification rate, endoscopist’s background, and concordance between EGD and pathology. Cohen’s Kappa test was used for concordance analysis. Results: A total of 110 patients had EGD findings of GAVE with a corresponding 184 EGDs. The misclassification rate amongst EGDs was 74/184 (40%). Furthermore, 81/110 patients were correctly classified with their first workup, whereas 29/110 patients needed repeat testing. In cases of misclassification, GAVE was mostly referred to as erythema (43%), with ulceration, gastritis, or polyps. Sixty-six (60%) patients had biopsies with a concordance of 76% between EGD and biopsy (κ=0.35) Conclusions: Our findings indicate GAVE was misclasssified up to 40% on EGDs with hepatologists and gastroenterologists having similar misclassification rates. Proper identification is crucial given susceptibility to upper gastrointestinal bleeding. Relevance for patients: This study emphasizes the importance of accurate classification of GAVE to ensure proper treatment of these lesions which can improve clinical outcomes.